[1] Schröder JM, Harder J. Human beta-defensin-2[J].Int J Biochem Cell Biol, 1999, 31(6):645-651. [2] Harder J, Bartels J, Christophers E,et al. A peptide antibiotic from human skin[J]. Nature, 1997, 387(6636):861. [3] Katagiri S, Park K, Maeda Y,et al. Overexpressing IRS1 in endothelial cells enhances angioblast differentiation and wound healing in diabetes and insulin resistance[J]. Diabetes, 2016, 65(9):2760-2771. [4] 郭峰, 李涛, 韩燃, 等. 人β防御素1~4抑菌及盐敏感性研究[J]. 安徽医科大学学报, 2013, 48(8):885-889. [5] Wilmes M, Cammue BP, Sahl HG,et al. Antibiotic activities of host defense peptides:More to it than lipid bilayer perturbation[J]. Nat Prod Rep, 2011, 28(8):1350-1358. [6] Kim J, Yang YL, Jang YS. Human β-defensin 2 is involved in CCR2-mediated Nod2 signal transduction, leading to activation of the innate immune response in macrophages[J]. Immunobiology, 2019, 224(4):502-510. [7] BiragynA, Ruffini PA, Leifer CA, et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2[J]. Science, 2002, 298(5595):1025-1029. [8] Ghosh SK, McCormick TS, Weinberg A. Human beta defensins and cancer:Contradictions and common ground[J]. Front Oncol, 2019, 9:341. [9] Bautista-Hernández LA, Gómez-Olivares JL, Buentello-Volante B,et al. Fibroblasts:The unknown sentinels eliciting immune responses against microorganisms[J]. Eur J Microbiol Immunol (Bp), 2017, 7(3):151-157. [10] Langfeldt D, Neulinger SC, Stiesch M,et al. Health- and disease-associated species clusters in complex natural biofilms determine the innate immune response in oral epithelial cells during biofilm maturation[J]. FEMS Microbiol Lett, 2014, 360(2):137-143. [11] 郭贤利. 人β防御素2重组蛋白体外抑菌实验及抗肿瘤细胞毒性探究[J]. 现代医学与健康研究电子杂志, 2018, 2(11):177,179. [12] Nittayananta W. Oral fungi in HIV:Challenges in antifungal therapies[J]. Oral Dis, 2016, 22(Suppl 1):107-113. [13] Abiko Y, Jinbu Y, Noguchi T,et al. Upregulation of human beta-defensin 2 peptide expression in oral lichen planus, leukoplakia and candidiasis. An immunohistochemical study[J]. Pathol Res Pract, 2002, 198(8):537-542. [14] 邹杰. 口腔扁平苔藓患者hBD2和LL-37的表达与口腔白色念珠菌的相关关系研究[D]. 南宁:广西医科大学, 2006. [15] 刘东娟, 陈谦明. 口腔扁平苔藓的诊断与治疗[J]. 中国实用口腔科杂志, 2017, 10(9):518-521,525. [16] 王雪薇, 唐楠, 赵知白, 等. 口腔扁平苔藓黏膜病损区微生物群落分析[J]. 口腔医学, 2020, 40(2):108-112. [17] Carvalho MFMS, Cavalieri D, Do Nascimento S,et al. Cytokines levels and salivary microbiome play a potential role in oral lichen planus diagnosis[J]. Sci Rep, 2019, 9(1):18137. [18] Wang XW, Zhao ZB, Tang N,et al. Corrigendum: Microbial community analysis of saliva and biopsies in patients with oral lichen planus[J]. Front Microbiol, 2020, 11:1282. [19] Szukiewicz D, Alkhalayla H, Pyzlak M,et al. Human beta-defensin 1, 2 and 3 production by amniotic epithelial cells with respect to human papillomavirus (HPV) infection, HPV oncogenic potential and the mode of delivery[J]. MicrobPathog, 2016, 97:154-165. [20] 赵雯雯, 毕庆伟, 李岩, 等. 口腔扁平苔藓患者黏膜脱落上皮中人β防御素-2和白色念珠菌的研究[J]. 医学研究杂志, 2016, 45(7):92-95. [21] Ellepola AN, Samaranayake LP. Inhalational and topical steroids, and oral candidosis:A mini review[J]. Oral Dis, 2001, 7(4):211-216. [22] Lodi G, Tarozzi M, Sardella A,et al. Miconazole as adjuvant therapy for oral lichen planus:A double-blind randomized controlled trial[J]. Br J Dermatol, 2007, 156(6):1336-1341. [23] Casaroto AR, da Silva RA, Salmeron S,et al. Candida albicans-cell interactions activate innate immune defense in human palate epithelial primary cells via nitric oxide (NO) and β-defensin 2 (hBD-2)[J]. Cells, 2019, 8(7):E707. [24] 黄韵颖, 周塑,蔡扬. 口腔扁平苔藓患者血清中白细胞介素-12和白细胞介素-27表达与免疫功能的相关性[J]. 华西口腔医学杂志, 2016, 34(2):140-144. [25] 王安训. 口腔黏膜相关疾病免疫功能检测及意义[J]. 口腔疾病防治, 2021, 29(2):73-80. [26] Chiang CP, Yu-Fong Chang J, Wang YP, et al. Oral lichen planus-Differential diagnoses, serum autoantibodies, hematinic deficiencies, and management[J].Taiwan Yi Zhi, 2018, 117(9):756-765. [27] DeAngelis LM, Cirillo N, McCullough MJ. The immunopathogen-esis of oral lichen planus-Is there a role for mucosal associated invariant T cells?[J]. J Oral Pathol Med, 2019, 48(7):552-559. [28] Mutafchieva MZ, Draganova-Filipova MN, Zagorchev PI,et al. Oral lichen planus-known and unknown:A review[J]. Folia Med (Plovdiv), 2018, 60(4):528-535. [29] Giuliani M, Troiano G, Cordaro M,etal. Rate of malignant transformation of oral lichen planus:A systematic review[J]. Oral Dis, 2019, 25(3):693-709. [30] Idrees M, Kujan O, Shearston K,etal. Oral lichen planus has a very low malignant transformation rate:A systematic review and meta-analysis using strict diagnostic and inclusion criteria[J]. J Oral Pathol Med, 2021, 50(3):287-298. [31] Jayaraj R, Shetty SS, Kumaraswamy C,et al. Clinical interpreta-tion of findings from a systematic review and a comprehensive meta-analysis on clinicopathological and prognostic characteristics of oral squamous cell carcinomas (OSCC) arising in patients with oral lichen planus (OLP)[J]. Oral Oncol, 2020, 108:104974. [32] Gainza-Cirauqui ML, Nieminen MT, Novak Frazer L ,et al. Production of carcinogenic acetaldehyde by Candida albicans from patients with potentially malignant oral mucosal disorders[J]. J Oral Pathol Med. 2013, 42(3):243-249. [33] Alburquenque C, Amaro J, Fuentes M,et al. Protective effect of inactivated blastoconidia in keratinocytes and human reconstituted epithelium against C. albicans infection[J]. Med Mycol, 2019, 57(4):457-467. [34] Kesting MR, Mueller C, Wagenpfeil S,et al. Quantitative comparison of the expression of antimicrobial peptides in the oral mucosa and extraoral skin[J]. Br J Oral Maxillofac Surg, 2012, 50(5):447-453. [35] 米博斌. 改良型人源性防御素2通过诱导角质细胞增殖和迁移促进创面愈合[D]. 武汉:华中科技大学, 2019. |